Clinical Trials Browser

OTHER × tasquinimod × Plasma cell × Clear all

NCT04405167 2025-10-07

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Phase 1 Terminated

Multiple Myeloma